The addition of radiation therapy to hormone therapy for the treatment of locally advanced prostate cancer reduces prostate cancer deaths by 50%, according to the results of a Scandinavian study published in the Lancet.
According to the results of two large randomized studies, selenium and vitamin E supplements do not reduce the risk of prostate cancer. These results were published in the Journal of the American Medical Association.
The use of cholesterol-lowering drugs known as statins is associated with a decline in prostate specific antigen (PSA) levels, according to the results of a study published in the November 5, 2008 issue of the Journal of the National Cancer Institute.
